Drug: trastuzumab Quarter: 2016Q3
Total Drug/Injury Combinations: 450 Number of Pages: 23
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| Trastuzumab Emtansine | General physical health deterioration | 1 | view events |
| Trastuzumab Emtansine | Guillain-Barre syndrome | 1 | view events |
| Trastuzumab Emtansine | Haematuria | 1 | view events |
| Trastuzumab Emtansine | Haemoptysis | 1 | view events |
| Trastuzumab Emtansine | Haemorrhage intracranial | 1 | view events |
| Trastuzumab Emtansine | Hydrocephalus | 1 | view events |
| Trastuzumab Emtansine | Hyperammonaemia | 1 | view events |
| Trastuzumab Emtansine | Hyperglycaemia | 1 | view events |
| TRASTUZUMAB EMTANSINE | Intestinal obstruction | 1 | view events |
| Trastuzumab Emtansine | Left ventricular hypertrophy | 1 | view events |
| Trastuzumab Emtansine | Lower gastrointestinal haemorrhage | 1 | view events |
| Trastuzumab Emtansine | Lymphocyte count decreased | 1 | view events |
| Trastuzumab Emtansine | Mastitis | 1 | view events |
| Trastuzumab Emtansine | Metastases to central nervous system | 1 | view events |
| Trastuzumab Emtansine | Multiple organ dysfunction syndrome | 1 | view events |
| Trastuzumab Emtansine | Myocardial infarction | 1 | view events |
| TRASTUZUMAB EMTANSINE | Nail bed disorder | 1 | view events |
| TRASTUZUMAB EMTANSINE | Neurotoxicity | 1 | view events |
| Trastuzumab Emtansine | Nodular regenerative hyperplasia | 1 | view events |
| Trastuzumab Emtansine | Orthostatic hypotension | 1 | view events |
Total Drug/Injury Combinations: 450 Number of Pages: 23
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)